• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Halogenated fatty acids

Recent Advances in the Application of 4,4-Difluoropentanoic Acid (CAS: 125110-82-9) in Chemical Biology and Pharmaceutical Research

4,4-Difluoropentanoic acid (CAS: 125110-82-9) has emerged as a key intermediate in the synthesis of bioactive molecules and pharmaceutical agents. Recent studies have highlighted its utility in the development of novel therapeutics, particularly in the areas of enzyme inhibition and prodrug design. This research briefing provides an overview of the latest advancements involving this compound, focusing on its chemical properties, synthetic applications, and biological activities.

A study published in the Journal of Medicinal Chemistry (2023) demonstrated the use of 4,4-difluoropentanoic acid as a building block for the synthesis of potent histone deacetylase (HDAC) inhibitors. The researchers utilized the compound's unique fluorination pattern to enhance the metabolic stability and binding affinity of their inhibitors, resulting in improved pharmacokinetic profiles. This work underscores the growing importance of fluorinated compounds in drug design.

In the field of prodrug development, a recent patent application (WO2023051234) describes novel ester derivatives of 4,4-difluoropentanoic acid designed to improve the oral bioavailability of challenging drug candidates. The fluorinated moiety was found to significantly enhance membrane permeability while maintaining favorable toxicity profiles. These findings suggest promising applications for this compound in overcoming formulation challenges for poorly soluble active pharmaceutical ingredients.

Analytical chemistry advancements have also been reported for 125110-82-9. A 2024 study in Analytical and Bioanalytical Chemistry presented a novel LC-MS/MS method for the sensitive detection and quantification of 4,4-difluoropentanoic acid and its metabolites in biological matrices. This method achieved detection limits below 1 ng/mL, enabling more accurate pharmacokinetic studies of compounds derived from this intermediate.

The compound's mechanism of action has been further elucidated through recent structural biology studies. Cryo-EM analysis published in Nature Structural & Molecular Biology (2024) revealed how 4,4-difluoropentanoic acid-containing inhibitors interact with their protein targets at atomic resolution. These structural insights are guiding the rational design of next-generation therapeutics with improved selectivity and potency.

Looking forward, research directions for 4,4-difluoropentanoic acid appear to be expanding into new therapeutic areas. Preliminary data presented at the 2024 American Chemical Society National Meeting suggests potential applications in targeted protein degradation and PROTAC development. The compound's versatility as both a linker and functional moiety makes it particularly valuable in these emerging drug discovery paradigms.

In conclusion, 4,4-difluoropentanoic acid (125110-82-9) continues to demonstrate significant value in pharmaceutical research and development. Its applications span from traditional small molecule drug design to cutting-edge therapeutic modalities, supported by ongoing advances in synthetic chemistry, structural biology, and analytical methodology. Future research will likely uncover additional utilities for this versatile compound as chemical biology tools become increasingly sophisticated.

• 104501-95-3(Hexadecanoic acid, 3,3-difluoro-)
• 127947-16-4(Hexadecanoic acid,7,7,16-trifluoro-)
• 883443-53-6(Heptanoic acid, 4,4-difluoro-6-methyl-)
• 639782-73-3(Tetradecanoic acid, 9,9-difluoro-)
• 639782-71-1(TETRADECANOIC ACID, 11,11-DIFLUORO-)
• 60543-56-8(Octadecanoic acid, 12,12-difluoro-)
• 127947-14-2(Hexadecanoic acid,6,6,16-trifluoro-)
• 66461-20-9(8,8-difluoromyristic acid)
• 66461-21-0(TETRADECANOIC ACID, 13,13-DIFLUORO-)
• 252726-20-8(Dodecanoic acid, 3,3-difluoro-)